Diabetes
Poster Session 3
Nicole Feigenblum, BS, MD (she/her/hers)
PGY-1
Hackensack University Medical Center
Englewood, NJ, United States
Tamar Itzkowitz, BS
Hackensack Meridian School of Medicine
Nutley, NJ, United States
Colette Knight, MD
Hackensack University Medical Center
Hackensack, NJ, United States
Toni Isabella, RN
Molly Diabetes Education Center
Maywood, NJ, United States
Christine Moore, BS, RN
Hackensack University Medical Center
Hackensack, NJ, United States
Antonia F. Oladipo, MD, MSCI (she/her/hers)
Assistant Professor
Hackensack University Medical Center
Hackensack, NJ, United States
Patients with Gestational Diabetes Mellitus (GDM) are at increased risk for developing Type II Diabetes Mellitus (T2DM). Postpartum screening for T2DM is lacking and presents challenges, with less than 50% of patients undergoing recommended follow up. We aim to understand risk perception and knowledge surrounding screening adherence to T2DM.
Study Design:
An IRB-approved, prospective study between August 1, 2022 to July 31, 2023 surveying patients diagnosed with GDM in a single hospital system. Data was collected at three timepoints - twice at antenatal diabetes education appointments and once postpartum prior to discharge from hospital. The survey was adapted from the Risk Perception Survey for Developing Diabetes (RPS-DD). Understanding patient’s perception and ensuring that we continue to educate and raise awareness surrounding their immediate and long-term risks related to development of T2DM is paramount. Education should highlight the increased risk of T2DM development in the 3-10 years post delivery. Further research is needed to understand how risk perception influences screening adherence.
Results: A total of 136 individuals participated in the study at least one time point. Twenty-two of these participants completed the survey at two time points. A total of 158 surveys were collected. Prior to study participation, 51.3% of patients had formal diabetes education. Patients believed that factors associated with T2DM development include previous GDM (66.9%), family history of T2DM (56.3%), and lifestyle factors (25.2%). Knowledge on racial discrepancies and diabetes diagnosis was limited, with only one third of respondents stating that non-white races (including Asian American, Black, Hispanic, and American Indian) are associated with increased risk of developing T2DM. Additionally, in comparison to women in their age group, 74.7% of GDM patients believe they are more likely to develop T2DM. Interestingly, only 50.7% believe they have increased immediate risk of developing T2DM over the next 10 years.
Conclusion: